INBRAIN Neuroelectronics
PrivateLast Round
Grant
May 6, 2025
Total Funding Raised
$72.22M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
INBRAIN Neuroelectronics operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Grant round in May 2025.
INBRAIN Neuroelectronics is a medical technology company that develops graphene-based, AI-powered brain-computer interface (BCI) therapies for neurological conditions such as Parkinson's and epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Medical AI, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INBRAIN Neuroelectronics Comparables
Compare INBRAIN Neuroelectronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precision Neuroscience | 86% | |
| Axoft | 83% | |
| Neurosoft Bioelectronics | 81% |
For institutional investors. Book with your work email.
INBRAIN Neuroelectronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 6, 2025 | ||||
| Series B | Oct 29, 2024 | ||||
| Series A | Mar 30, 2021 | ||||
| Seed | Jun 29, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
INBRAIN Neuroelectronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series B, Series A, Seed |
| Alta Life Sciences | Series A, Seed |
| ICF Venture Tech II | Series A |
| Avançsa | Series B |
| Ysios Capital | Seed |
| Fond-ICO Next Tech | Series B |
| imec.xpand | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 232% MoM, reaching 5.4K.
- Jun 4, 2026
4-year collaboration with Merck KGaA to develop peripheral nervous system therapies.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 20, 2026
Inbrain Neuroelectronics, born from local research collaboration, is developing non-invasive neuroelectronic therapies for brain disorders using graphene and AI-driven smart interfaces in Spain.
- partners_withOct 8, 2026
Inbrain Neuroelectronics works with Robeaute to examine microrobotic methods for neural device placement on Oct 8th '26.
- is_developingOct 7, 2026
Inbrain Neuroelectronics develops magnetically guided robotic implantation for ultra-thin graphene brain-computer interfaces through the completed MINIGRAPH project, which integrates graphene neural interfaces, implantable electronics, autonomous software, and a minimally invasive procedure for next-generation neurotherapies in Spain.
- is_developingOct 7, 2026
Inbrain Neuroelectronics is developing a graphene BCI platform with a clinical focus on therapeutic applications in epilepsy and other neurological conditions.
- launchesOct 7, 2026
Inbrain Neuroelectronics announces a magnetically guided robotic implantation system designed for ultra-thin graphene-based neural interfaces on Oct 7th '26.
For institutional investors. Book with your work email.
INBRAIN Neuroelectronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about INBRAIN Neuroelectronics's valuation, stock price, and market status.
Is INBRAIN Neuroelectronics a public or private company?
INBRAIN Neuroelectronics is a private company.
What is the current stock price of INBRAIN Neuroelectronics?
INBRAIN Neuroelectronics is a private company, so its shares have no public market price. Caplight tracks INBRAIN Neuroelectronics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is INBRAIN Neuroelectronics worth (valuation)?
Valuation information for INBRAIN Neuroelectronics is not publicly available.
Can I buy INBRAIN Neuroelectronics stock?
INBRAIN Neuroelectronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was INBRAIN Neuroelectronics's last funding round?
INBRAIN Neuroelectronics's most recent funding round was Grant on May 6, 2025.
Who are the main investors in INBRAIN Neuroelectronics?
Key investors in INBRAIN Neuroelectronics include Asabys Partners, Alta Life Sciences, imec.xpand.
Will INBRAIN Neuroelectronics IPO soon?
No public IPO plans have been announced for INBRAIN Neuroelectronics.
How can I track INBRAIN Neuroelectronics secondary market activity?
Caplight tracks bids, offers, and trades in INBRAIN Neuroelectronics's shares on secondary markets.